DeltaPoint, Inc.

DeltaPoint, Inc., is an early stage medical technology company based in Portland, Oregon, developing a non-invasive method for diagnosing and monitoring cancer. DeltaPoint is commercializing a patent-pending cancer diagnostic imaging biomarker - by analyzing dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) data. The biomarker is the first to reliably and non-invasively discriminate benign from malignant tumors. The company is initially focused on the breast cancer market.